ShiraTronics begins clinical trials, raises $5M for chronic migraine relief

Brooklyn Park-based ShiraTronics has raised $41 million to-date in its efforts to treat patients with chronic migraines.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 30, 2023 Category: Pharmaceuticals Authors: J.D. Duggan Source Type: news